Hemorrhagic cerebrovascular disease
Conditions
Interventions
Intervention Group:oral 3g HMB
control group:placebo
Sponsors
Zhongshan Hospital Affiliated to Xiamen University
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. The informed consent is signed voluntarily by the subject or the legal representative of the subject; 2. Subjects aged 20-70 years old; 3. Subjects with stable hemodynamics and risk of malnutrition; 4. Subjects with enteral nutrition support or oral feeding.
Exclusion criteria
Exclusion criteria: 1. Hunt Hess grade V subjects; 2. Subjects with GCS score 8%); 9. Patients with autoimmune diseases requiring immunosuppressive therapy; 10. Patients who could not accept tube feeding; 11. Patients with cerebral hemorrhage of unknown cause; 12. Subjects with any other conditions or events that the principal investigator or study physician considers inappropriate for inclusion; 13. Subjects who are allergic or intolerant to any component in the study product; 14. Subjects in another clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Weight of lean body mass; | — |
Countries
China
Contacts
Public ContactCai Xueping
Zhongshan Hospital Affiliated to Xiamen University
Outcome results
None listed